"Il NSI, attivo dal 1° luglio 2009, permette di rispondere nel modo più appropriato, evitando inutili ridondanze, all’esigenza di sinergia fra le diverse specialità mediche nell'ambito delle Neuroscienze cliniche, offrendo ai pazienti un approccio alla malattia e un trattamento delle patologie all'avanguardia e sicuri, che considerano il percorso diagnostico-terapeutico e riabilitativo del paziente dalle prime ore della malattia fino al rientro a domicilio. All'interno del Neurocentro sono presenti Neurologia, Neurochirurgia, Neuroradiologia, Centro per la terapia del dolore e Neuroanestesia, Neuropsicologia e Neuroscienze."

During the past decade, Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland" #1 collaborator was "ABREOC" with 1 trials as a collaborator, "Philips Respironics" with 1 trials as a collaborator, "ResMed" with 1 trials as a collaborator, "Schweizerische Herzstiftung" with 1 trials as a collaborator and "Swiss National Science Foundation" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland" are "Iron Deficiency Anemia" (1 trials), "Ischemic Stroke" (1 trials), "Multiple Sclerosis" (1 trials), "Multiple Sclerosis, Relapsing-Remitting" (1 trials) and "Restless Leg Syndrome" (1 trials). Many other conditions were trialed in "Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland" in a lesser frequency.

Most popular intervention types in "Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland" are "Device" (2 trials), "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "CPAP" (1 trials), "StimRouter®, Self-activated and self-controlled neuromodulation device (Bioness Inc, CE0086)." (1 trials), "eCoin" (1 trials) and "ferric carboxymaltose" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland" are 3 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ospedale Regionale di Lugano, Neurocenter of Southern Switzerland, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 2 trials that are defined as “Not Applicable".